New hope for controlling devastating childhood epilepsies
Disease control
Completed
This study tested the long-term safety of an add-on epilepsy drug called LP352 for people with severe, hard-to-treat epilepsies like Dravet and Lennox-Gastaut syndromes. It followed 41 participants for up to a year to see if the drug was safe to take continuously and if it helped…
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Feb 18, 2026 14:07 UTC